Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,28,0.99 [0.91-1.07],0.729119010296497
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,28,0.98 [0.95-1.01],0.160008180973809
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,28,0.99 [0.96-1.01],0.397508669921144
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,28,0.96 [0.91-1.01],0.12708594942382
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,28,1.01 [0.99-1.04],0.311275982792326
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,28,0.94 [0.69-1.26],0.672069580253179
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,28,1.03 [0.98-1.07],0.221656828528
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,28,0.91 [0.60-1.38],0.6631554189032
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,Inverse variance weighted,28,0.82 [0.67-1.00],0.0539603621721855
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,28,1.01 [0.96-1.07],0.663444478623592
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,28,1.00 [0.95-1.04],0.828706631417966
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,28,1.00 [0.91-1.10],0.971478158322216
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,28,1.06 [0.92-1.22],0.436199772517787
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,28,0.96 [0.86-1.07],0.460449092148732
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,28,0.96 [0.89-1.03],0.218718378442738
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,28,1.00 [0.95-1.05],0.853287719736938
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,Inverse variance weighted,28,0.99 [0.91-1.09],0.887035928847703
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,Inverse variance weighted,28,0.74 [0.52-1.07],0.110112100719837
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,28,0.97 [0.79-1.18],0.744586785823694
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,28,1.01 [0.96-1.06],0.714715796534917
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,28,1.01 [0.96-1.05],0.798534563091869
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,28,0.96 [0.72-1.27],0.764283384552325
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,28,0.94 [0.87-1.01],0.1057625680951
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,Inverse variance weighted,28,1.07 [0.99-1.16],0.0968867396212305
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,28,0.98 [0.87-1.09],0.664922151854396
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,28,1.02 [0.94-1.10],0.655299028742579
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,28,0.95 [0.86-1.04],0.241353816466967
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,28,1.25 [0.97-1.60],0.0837794733075075
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,28,0.97 [0.87-1.09],0.617949386104889
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,28,1.01 [0.93-1.09],0.876133028384904
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,28,0.98 [0.87-1.09],0.661805756956385
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,28,1.00 [0.91-1.10],0.966124672951149
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,28,1.00 [0.96-1.04],0.950681376927742
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",Inverse variance weighted,28,1.05 [0.95-1.17],0.320524717359658
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,28,0.67 [0.51-0.88],0.0044882598270065
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,28,1.03 [0.97-1.09],0.35450207999987
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,28,0.96 [0.88-1.06],0.45971254562401
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,28,0.98 [0.86-1.11],0.728808392993488
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,28,0.99 [0.95-1.04],0.781312908837047
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,Inverse variance weighted,28,0.83 [0.64-1.08],0.173940021282275
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,28,0.93 [0.87-1.00],0.0395216181700748
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,28,0.98 [0.90-1.06],0.583583680631284
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,28,1.05 [0.97-1.13],0.252332185829533
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,28,0.99 [0.97-1.02],0.606181203822388
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,28,1.00 [0.98-1.03],0.873032437449503
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,28,0.85 [0.58-1.26],0.427267665865577
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,28,1.02 [0.89-1.17],0.785510564347531
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,Inverse variance weighted,28,0.98 [0.95-1.02],0.297750503815546
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",Inverse variance weighted,28,0.98 [0.94-1.03],0.515846279482948
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,28,0.92 [0.87-0.98],0.012354312350273
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,28,1.27 [0.88-1.82],0.199474770338477
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,28,1.02 [1.00-1.05],0.0939673091746282
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,Inverse variance weighted,28,1.08 [0.89-1.31],0.450798940209215
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,28,0.89 [0.70-1.13],0.345379172077564
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,28,0.98 [0.88-1.09],0.713164735396329
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,28,1.05 [0.94-1.17],0.412321869583485
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,Inverse variance weighted,28,0.97 [0.90-1.05],0.455499875351194
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,28,1.01 [0.99-1.04],0.372496621714006
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,28,1.01 [0.98-1.03],0.655536220374066
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,28,0.99 [0.98-1.01],0.540380212009414
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,28,1.02 [0.93-1.11],0.72463402660868
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,28,0.99 [0.97-1.01],0.303011228037345
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,28,0.98 [0.94-1.02],0.367461886860435
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,28,1.03 [0.89-1.20],0.678190292916121
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,28,0.98 [0.96-1.01],0.181759572593566
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Other neurological diseases,Inverse variance weighted,28,1.01 [0.98-1.04],0.620014431585191
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,28,0.99 [0.92-1.07],0.841290412589604
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,28,1.09 [1.02-1.16],0.0163782737127203
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,Inverse variance weighted,28,0.96 [0.92-1.00],0.0312488047700323
SPINK1,Serine protease inhibitor Kazal-type 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,28,0.99 [0.96-1.02],0.392172504185411
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),Inverse variance weighted,28,0.91 [0.83-1.00],0.0545699548749353
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,28,1.03 [0.99-1.07],0.13580655172065
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,28,0.98 [0.95-1.02],0.328603781729066
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Aortic aneurysm,Inverse variance weighted,28,0.96 [0.89-1.04],0.301434586134315
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,28,1.05 [0.90-1.22],0.532393106048388
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,28,1.08 [0.91-1.28],0.373008128047971
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,28,1.01 [0.92-1.11],0.827333004299914
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,28,0.97 [0.93-1.01],0.114024004444723
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,AV-block,Inverse variance weighted,28,0.98 [0.91-1.05],0.504892118362615
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,28,1.03 [0.93-1.15],0.553985873562088
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,28,0.94 [0.87-1.01],0.103751055220785
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",Inverse variance weighted,28,0.93 [0.84-1.03],0.173069581354524
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,28,1.02 [0.91-1.14],0.746814659897443
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,28,1.01 [0.98-1.04],0.480765205983427
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,28,1.01 [0.96-1.06],0.820218043128229
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,28,0.98 [0.95-1.02],0.341960184398179
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,28,1.01 [0.98-1.05],0.397462214078917
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,28,1.00 [0.93-1.08],0.938441808409949
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,28,1.01 [0.98-1.03],0.590926983709964
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,28,1.00 [0.98-1.02],0.739172048643632
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,28,1.00 [0.73-1.38],0.987344932678104
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,28,0.85 [0.73-1.00],0.0485714723870788
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,28,1.00 [0.97-1.03],0.944199443855823
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,28,1.03 [0.99-1.07],0.198607406183991
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,28,1.05 [0.94-1.17],0.405711707936768
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,28,1.02 [0.98-1.06],0.284518072420013
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,28,1.16 [1.02-1.32],0.0216899945627872
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,28,0.99 [0.90-1.10],0.907932874167246
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,28,0.98 [0.93-1.04],0.51518834174173
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,28,0.97 [0.91-1.02],0.253501327305102
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,28,0.91 [0.85-0.98],0.0150899691514311
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,28,0.95 [0.90-1.00],0.0710984740803429
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,28,1.01 [0.86-1.18],0.950134329712378
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,28,1.01 [0.83-1.23],0.926553838132465
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,28,0.94 [0.80-1.11],0.490628558209769
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,28,1.02 [0.97-1.07],0.452962783021024
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,28,1.01 [0.98-1.05],0.434403866750082
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,28,0.95 [0.91-1.00],0.0471115144640027
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,28,0.99 [0.92-1.07],0.793752488462396
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,28,1.05 [0.98-1.13],0.134483594856143
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,28,1.01 [0.94-1.08],0.822133861424607
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,28,0.99 [0.97-1.02],0.706924351251708
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,28,0.95 [0.86-1.05],0.327220744325699
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,28,1.08 [0.93-1.26],0.324143100049043
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,28,0.96 [0.89-1.04],0.316315924896989
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,28,1.04 [0.99-1.10],0.140960608514278
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,28,1.00 [0.98-1.03],0.86546499941706
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,28,1.00 [0.98-1.03],0.716766505788774
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,28,1.02 [0.98-1.05],0.302422363098126
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,28,0.99 [0.95-1.04],0.739001860882782
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,28,1.00 [0.93-1.08],0.930661365111218
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,28,1.01 [0.91-1.12],0.819229267085749
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,28,1.00 [0.79-1.28],0.979158045649811
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,Viral pneumonia,Inverse variance weighted,28,1.01 [0.92-1.12],0.811049869485252
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,28,0.98 [0.95-1.02],0.305612512480138
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Barrett oesophagus,Inverse variance weighted,28,0.90 [0.78-1.04],0.166391809555111
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",Inverse variance weighted,28,1.06 [0.93-1.21],0.368609178857056
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,28,1.00 [0.95-1.04],0.89766378666207
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,28,0.98 [0.95-1.01],0.149924198828979
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,Inverse variance weighted,28,1.00 [0.96-1.05],0.955902454032659
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,28,1.04 [0.95-1.14],0.382027446914001
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,28,0.99 [0.95-1.03],0.690798863508421
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,Inverse variance weighted,28,0.95 [0.88-1.03],0.234683984094442
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,28,0.98 [0.94-1.02],0.249724005561557
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,28,1.05 [0.94-1.18],0.37592570708703
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,Inverse variance weighted,28,0.98 [0.93-1.03],0.389258798707697
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Gastric ulcer,Inverse variance weighted,28,0.97 [0.91-1.03],0.324238187391
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,28,1.10 [0.94-1.29],0.221836251461441
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Hernia,Inverse variance weighted,28,1.00 [0.98-1.02],0.98869009248773
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,Inverse variance weighted,28,0.98 [0.93-1.03],0.485296741384052
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,28,0.99 [0.97-1.02],0.505742855698936
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,28,1.01 [0.96-1.07],0.624113828928896
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Oesophagitis,Inverse variance weighted,28,0.82 [0.72-0.93],0.0018354985615262
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,28,0.98 [0.96-1.01],0.169486759268575
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,Inverse variance weighted,28,0.89 [0.80-1.00],0.0456750443725083
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,28,0.98 [0.94-1.02],0.299711389991784
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,28,0.98 [0.94-1.03],0.51324419213007
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,Inverse variance weighted,28,0.99 [0.89-1.10],0.782448333313796
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,28,1.00 [0.87-1.15],0.99819771769042
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,28,0.98 [0.92-1.03],0.365144975101875
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,28,0.99 [0.95-1.03],0.501822144330461
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,28,1.02 [0.96-1.08],0.588923942407588
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",Inverse variance weighted,28,0.99 [0.93-1.05],0.756397514802934
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,28,0.99 [0.91-1.08],0.899362138963802
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,28,0.88 [0.75-1.03],0.113876561067645
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,28,1.03 [0.92-1.15],0.603895784296106
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,Inverse variance weighted,28,1.07 [0.97-1.19],0.19148963964324
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,Inverse variance weighted,28,1.05 [0.94-1.18],0.359679514686761
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XI Diseases of the digestive system,Ventral hernia,Inverse variance weighted,28,1.04 [0.98-1.10],0.191750487439203
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",Inverse variance weighted,28,1.03 [1.00-1.06],0.0416642815669156
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,28,1.00 [0.98-1.02],0.845519479851798
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,28,1.00 [0.96-1.04],0.985946852527135
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,28,0.97 [0.92-1.03],0.376756169516732
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,28,1.10 [0.97-1.25],0.135618582876593
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,Inverse variance weighted,28,0.98 [0.95-1.00],0.0827905458386398
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,28,1.01 [0.97-1.04],0.711834828007425
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,Inverse variance weighted,28,0.97 [0.88-1.07],0.573783267844898
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,28,0.98 [0.95-1.02],0.267409248685244
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,28,0.97 [0.88-1.06],0.465217985268092
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,28,0.98 [0.96-1.01],0.147681414214692
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,28,0.98 [0.96-1.01],0.17794766532789
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,28,0.97 [0.94-1.01],0.143130566652545
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,Inverse variance weighted,28,0.99 [0.95-1.04],0.827842770122105
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,28,1.00 [0.98-1.02],0.821900662034926
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,28,1.00 [0.98-1.02],0.936088048635801
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,28,1.06 [1.00-1.12],0.0546203234035051
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,Inverse variance weighted,28,0.99 [0.96-1.03],0.731999895675388
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,28,0.99 [0.95-1.03],0.560991406631454
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,Inverse variance weighted,28,0.99 [0.88-1.12],0.909092299555821
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,28,0.96 [0.91-1.02],0.16623036876054
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,28,0.98 [0.96-1.00],0.0406680983496191
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,28,1.00 [0.97-1.03],0.931428783506029
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,28,0.97 [0.92-1.02],0.199814250257335
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,28,0.99 [0.98-1.01],0.474410496319751
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,28,1.19 [1.04-1.36],0.0110972962108822
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,28,0.99 [0.97-1.02],0.636888432956018
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,Inverse variance weighted,28,1.00 [0.97-1.03],0.942052054481983
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,28,0.98 [0.91-1.07],0.689070315347609
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,28,1.09 [0.93-1.29],0.282853615069172
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,28,0.99 [0.93-1.06],0.833208940864783
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,Inverse variance weighted,28,0.97 [0.82-1.14],0.70809909862036
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,28,1.08 [0.93-1.27],0.307524506962371
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,28,1.04 [0.96-1.13],0.317560427563527
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,28,1.05 [0.97-1.15],0.236590017165512
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,28,1.05 [0.95-1.16],0.35525101334564
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,28,1.00 [0.92-1.08],0.989983021552584
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,28,1.13 [0.96-1.33],0.130505140188607
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,28,0.76 [0.54-1.05],0.092915916611767
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,28,1.01 [0.99-1.04],0.300168083922231
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,28,0.96 [0.86-1.07],0.454288621953219
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,28,1.01 [0.89-1.14],0.88986260452317
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,28,0.97 [0.94-1.00],0.0664405516811132
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,28,0.97 [0.95-1.00],0.0398688101695138
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,Inverse variance weighted,28,1.03 [0.98-1.07],0.25765062545213
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,28,0.99 [0.92-1.08],0.883244131755628
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,28,0.97 [0.90-1.05],0.505855980977439
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,28,0.94 [0.85-1.04],0.244733745435942
SPINK1,Serine protease inhibitor Kazal-type 1,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",Inverse variance weighted,28,0.93 [0.81-1.07],0.295166259706544
